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Massetolide A is a cyclic lipopeptide (CLP) antibiotic produced by various Pseudomonas strains from diverse
environments. Cloning, sequencing, site-directed mutagenesis, and complementation showed that massetolide
A biosynthesis in P. fluorescens SS101 is governed by three nonribosomal peptide synthetase (NRPS) genes,
designated massA, massB, and massC, spanning approximately 30 kb. Prediction of the nature and configura-
tion of the amino acids by in silico analysis of adenylation and condensation domains of the NRPSs was
consistent with the chemically determined structure of the peptide moiety of massetolide A. Structural analysis
of massetolide A derivatives produced by SS101 indicated that most of the variations in the peptide moiety
occur at amino acid positions 4 and 9. Regions flanking the mass genes contained several genes found in other
Pseudomonas CLP biosynthesis clusters, which encode LuxR-type transcriptional regulators, ABC transport-
ers, and an RND-like outer membrane protein. In contrast to most Pseudomonas CLP gene clusters known to
date, the mass genes are not physically linked but are organized in two separate clusters, with massA discon-
nected from massB and massC. Quantitative real-time PCR analysis indicated that transcription of massC is
strongly reduced when massB is mutated, suggesting that these two genes function in an operon, whereas
transcription of massA is independent of massBC and vice versa. Massetolide A is produced in the early
exponential growth phase, and biosynthesis appears not to be regulated by N-acylhomoserine lactone-based
quorum sensing. Massetolide A production is essential in swarming motility of P. fluorescens SS101 and plays
an important role in biofilm formation.
The cyclic lipopeptide (CLP) surfactant massetolide A con-
sists of a 9-amino-acid cyclic oligopeptide linked to 3-hydroxy-
decanoic acid and was first identified in cultures of a marine
Pseudomonas sp. isolated from the surface of a leafy red alga
collected in Masset Inlet, British Columbia, Canada (15). Mas-
setolide A was subsequently identified in Pseudomonas fluore-
scens SS101, a biocontrol strain isolated from the wheat rhizo-
sphere (10), and later described for Pseudomonas sp. strain
MF-30, a strain that inhibits the growth of the fungal patho-
gens Fusarium oxysporum and Drechslera teres (26). Like
several other CLPs produced by Pseudomonas and Bacillus
species (35, 43), massetolide A has potent surfactant and
broad-spectrum antimicrobial activities: it inhibits the growth
of Mycobacterium tuberculosis and Mycobacterium avium-intra-
cellulare (15) and has destructive effects on zoospores of mul-
tiple Oomycete plant pathogens, including Pythium and Phyto-
phthora species (8, 10). Massetolide A is an important
determinant of the activity of P. fluorescens SS101 against Phy-
tophthora infestans, the causal agent of late blight disease of
tomato, and contributes to the rhizosphere competence of
strain SS101 (55). The activity of massetolide A against the late
blight pathogen was attributed, at least in part, to its zoospori-
cidal activity and to the induction of a systemic resistance
response in tomato plants (55). In spite of its potential for the
control of plant and human pathogenic microorganisms, little
is known to date about the genes involved in massetolide A
biosynthesis in Pseudomonas.
Biosynthesis of CLPs is generally governed by multifunc-
tional nonribosomal peptide synthetases (NRPS) (43). NRPS
consist of several modules, each having a specific function in
the biosynthesis of CLPs and other peptide antibiotics (14, 16,
51). The number of NRPS modules is in most cases consistent
with the number of amino acids in the peptide moiety (“colin-
earity rule”). The modules can be further subdivided into ini-
tiation and elongation modules. Initiation modules typically
consist of an adenylation (A) domain, responsible for amino
acid selection and activation, and a thiolation (T) domain,
responsible for thioesterification of the activated amino acid
(13, 14). For CLP biosynthesis, however, the initiation module
also contains a condensation (C) domain, which is postulated
to catalyze N acylation of the first amino acid in the peptide
chain (27, 46). Elongation modules contain A, T, and C do-
mains, in which the C domain is responsible for peptide bond
formation between two neighboring substrates to elongate the
peptide chain. Collectively, these domains generate a linear
lipopeptide which is cleaved at the end of the assembly line by
a thioesterase (TE) domain, resulting in the release of a linear
product or a cyclic molecule via an intramolecular cyclization
reaction (5, 14, 25, 47, 51).
In this study, we describe the identification and character-
ization of the massetolide A biosynthesis genes from P. fluo-
rescens SS101. Transposon mutagenesis, bacterial artificial
chromosome (BAC) cloning, sequence analyses, site-directed
mutagenesis, and complementation revealed that massetolide
A biosynthesis is governed by three large NRPS genes, desig-
nated massA, massB, and massC. Sequence analysis of the
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regions flanking the mass genes was performed to identify the
presence of genes conserved in other CLP biosynthesis clus-
ters. Quantitative real-time PCR (Q-PCR) analysis was per-
formed to investigate the expression of each of the three mass
genes. The dynamics of massetolide A production by P. fluo-
rescens SS101, the identity of massetolide A derivatives pro-
duced by strain SS101, and the role of massetolide A in surface
motility and biofilm formation are presented.
MATERIALS AND METHODS
Bacterial strains and culture conditions. P. fluorescens SS101 was grown on
Pseudomonas agar F (Difco) plates or in liquid King’s medium B (KB) at 25°C.
The transposon mutants were obtained as described by De Souza et al. (10), and
plasposon mutants were obtained with plasmid pTnModOKm (9). Escherichia
coli strain DH5 and EPI3000 were used as hosts for the plasmids for site-
directed mutagenesis, complementation, and construction of the BAC library. E.
coli strains were grown on Luria-Bertani (LB) plates or in LB broth amended
with the appropriate antibiotics.
Site-directed mutagenesis. Site-directed mutagenesis of the mass genes was
performed with the pKnockout-G suicide vector (57). Fragments of the genes
of interest were amplified by PCR with the primers 5-CATTCCTGGCGTT
GGCTGG-3 (massA forward primer), 5-TGCAGCATTCCTCCAGCC
TG-3 (massA reverse primer), 5-AAATTCACGGGCGCTGGCAT-3 (massB
forward primer), 5-ACATGCCTCGTTGTCCCTGG-3 (massB reverse primer),
5-TCCTGGCGTTGATGGAAGG-3 (massC forward primer), and 5-AACG
ACAGGTCGAACTTGGC-3 (massC reverse primer) and first cloned into
pGEM-T Easy vector Systems I (Promega) according to the manufacturer’s
instructions. Inserts were subcloned by ApaI/SacI digestions into pKnockout-G
and transferred into SS101 by triparental mating with helper strain E. coli HB101
carrying plasmid pRK2013. Transformants were selected on KB agar plates
supplemented with rifampin (100 g/ml) and gentamicin (75 g/ml). Integrations
in the target gene were verified by PCR using one primer specific for the insert
and one primer specific for the gene fragment flanking the pKnockout insertion
site.
Construction of BAC library. P. fluorescens SS101 cells from a 25-ml overnight
culture grown at 25°C were washed twice with sterile demineralized water and
embedded in 1% low-melting-point agarose (Invitrogen) dissolved in TAE buffer
(40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.0). The cell-agarose mixture
was taken up into a 1-ml syringe and cooled down to 4°C to solidify. The
cell-agarose worm was extruded from the syringe and incubated with 10 ml of
lysis buffer (10 mM Tris, 50 mM NaCl, 0.2 M EDTA, 1% Sarkosyl, 0.2% sodium
deoxycholate, 1 mg/ml lysozyme, pH 8.0) with gentle agitation for 3 h at 37°C.
The agarose worms were subsequently transferred to 40 ml of 1% Sarkosyl and
proteinase K (1 mg/ml) and incubated with gentle agitation for 16 h at 55°C.
After refreshing of the buffer and incubation for 1 hour, agarose worms were
washed three times with 50 ml T10E1 buffer (10 mM Tris, 1 mM EDTA, pH 8.0)
and subsequently incubated for 1 hour at room temperature in T10E1 buffer
supplemented with 1 mM phenylmethylsulfonyl fluoride. The agarose worms
were washed three times with T10E1 buffer and incubated overnight in storage
buffer (10 mM Tris, 50 mM EDTA, pH 8.0). Pulse-field gel electrophoresis was
performed at 6 V/cm for 16 h with a 5- to 15-s switch time at a 120° angle to
analyze DNA yield and quality. Plugs were preincubated with Sau3AI digestion
buffer (New England Biolabs) and subsequently treated with Sau3AI. Partially
digested DNA was fractionated by pulse-field gel electrophoresis, and fragments
of 50 to 250 kb were isolated from agarose by Gelase (Epicenter) treatment
according to manufacturer’s instructions; 225 ng of DNA fragments was ligated
to 25 ng of BamHI-digested and dephosphorylated pCC1BAC vector DNA
(Epicenter) according to the supplier’s protocol and electroporated into E. coli
EPI3000 cells (Epicenter). Cells were plated on LB with chloramphenicol (12.5
g/ml).
Identification and sequencing of the mass genes. Library clones were blotted
onto Hybond N membranes (Amersham) and hybridized with 32P-labeled
probes amplified by PCR with the same primers as described for the site-directed
mutagenesis (see above). Hybridization was performed overnight, and mem-
branes were washed at 65°C with 0.5 SSC (75 mM NaCl, 7.5 mM sodium
citrate)–0.1% sodium dodecyl sulfate. Hybridization-positive clones were sub-
jected to detailed restriction digestion and hybridization analysis using PstI,
EcoRV, and previously described probes. Contigs were constructed by cluster
analysis of these experimental data by the unweighted-pair group method using
average linkages. Clones 2H12, containing massA, and 7B4, containing massB
and massC, were sent for shotgun sequencing (Macrogen, Seoul, Korea). Se-
quence gaps were closed by primer walking and by sequencing the PCR products
overlapping the gaps. Bacterial operons and genes were subsequently predicted
by the Softberry FGENESB program (Softberry, Inc., Mount Kisco, NY), and
the identified open reading frames (ORFs) were analyzed using Blastx in the
NCBI database and PseudoDB (http://xbase.bham.ac.uk/pseudodb/). Putative
promoter sequences were identified by the Softberry BPROM program, and
putative terminator sequences were identified by the RNA secondary structure
prediction program of Genebee (http://www.genebee.msu.su/). Specific domains
in the deduced protein sequences of the mass genes were analyzed with PFAM
(http://pfam.sanger.ac.uk/search?tabsearchSequenceBlock). Protein sequences
of specific domains were aligned in ClustalX (version 1.81). Trees were inferred
by neighbor joining using 1,000 bootstrap replicates. Identification of the flanking
genes of massA, massB, and massC was performed by Blastx analysis in NCBI,
Pseudomonas.com (http://v2.pseudomonas.com/), or PseudoDB and by compar-
ison with genes flanking the known CLP biosynthesis clusters for syringomycin,
syringopeptin, viscosin, orfamide, and arthrofactin.
Construction of pME6031-based vectors for complementation. A 7.7-kb frag-
ment containing the massA gene, including the promoter and terminator, was
obtained by PCR (forward primer, CAGACAAATCCTTCTTCACC; reverse
primer, GCGAGCTGCTGGATAACCCA) with Phusion DNA polymerase
(Finnzymes). This PCR fragment was subcloned in pGEM-T Easy vector systems
I (Promega) according to the manufacturer’s instructions, and the obtained
plasmid was digested with EcoRI. Restriction analysis of the BAC clone con-
taining massB and massC revealed unique restriction sites for BamHI. Digestion
with this enzyme resulted in a fragment of approximately 30 kb containing
massB, massC, and homologs of macA and macB. The fragments containing the
mass genes were obtained by excising the fragments from gel and isolating the
DNA with the NucleoTrap kit (Macherey-Nagel). These fragments were cloned
into the shuttle vector pME6031 (19), which was digested, dephosphorylated
(shrimp alkaline phosphatase; Promega), and purified with the NucleoTrap kit
according to the manufacturer’s instructions. E. coli DH5 was transformed with
the obtained plasmids pME6031-massA and pME6031-massBC by heat shock
transformation (20), and transformed colonies were selected on LB agar plates
supplemented with tetracycline (25 g/ml). Integration of the inserts was verified
by PCR analysis and restriction analysis of isolated plasmids. The correct
pME6031-massA and pME6031-massBC constructs were subsequently electro-
porated into the massetolide-deficient massA, massB, and massC transposon
mutants. Electrocompetent cells were obtained by washing the cells three times
with 1 mM MOPS (morpholinepropanesulfonic acid) and 15% glycerol from a
5-ml overnight culture and finally dissolving the cells in 100 l of the washing
buffer. Cells were stored at 80°C for at least 1 hour prior to electroporation.
Electroporation occurred at 2.4 kV and 200 F, and after incubation in SOC
medium (2% Bacto tryptone [Difco], 0.5% Bacto yeast extract [Difco], 10 mM
NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose [pH 7]) for
2 h at 25°C, cells were plated on KB supplemented with tetracycline (25 g/ml).
Verification of transformation was performed by PCR analysis using one primer
specific for the insert and one primer specific for the pME6031 vector. Masse-
tolide A production in the complemented mutants was tested with a drop col-
lapse assay followed by high-pressure liquid chromatography (HPLC) analysis
and liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Chemical identification of massetolide A derivatives produced by P. fluore-
scens SS101. Analytical HPLC separations were carried out on Alltech end-
capped 5-m C18 columns 250 mm in length and 4.6 mm (UV [210 nm] detection
and evaporative light-scattering detection) or 2.1 mm (LC-MS) in diameter at a
flow rate of 1.2 or 0.20 ml/min, respectively. For the separations on the 4.6-mm
column, a Midas autosampler (Spark), two Spectroflow 400 pumps (Kratos), a
Spectroflow UV detector 785 (Applied Biosystems), a Sedex 55 evaporative
light-scattering detector (Sedere) and Dionex Chromeleon software were used.
Preparative separations were performed with an Alltech end-capped 5-m C18
column (250 by 22 mm) at 23 ml/min with methyl cyanide-methanol-H2O (3,800:
1,925:4,275) containing 0.1% trifluoroacetic acid as the solvent on a Shimadzu
autopreparative system. Two hundred milligrams of crude surfactant extract of
strain SS101, obtained as described by De Souza et al. (10), was dissolved in 6 ml
dimethyl sulfoxide. After membrane filtration, five injections of 1,150 l each
were carried out. The fractions eluting at 47.2, 51.3, 57.0, 62.9, 65.0, 68.7, 79.4,
and 91.3 min were collected on the basis of the UV signal in round-bottom flasks,
and the eluent was removed with a rotary evaporator (Bu¨chi) in vacuo. All
fractions were investigated by means of analytical HPLC and infusion ()-
electrospray ionization (ESI)-MS/MS. The fractions at 57.0 and 65.0 min were
shown to contain a second, minor compound. Sufficient amounts of the fractions
at 62.9, 68.7, 79.4, and 91.3 min were collected to perform two-dimensional
nuclear magnetic resonance (NMR) experiments. The MS system consisted of a
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Finnigan LCQ ion trap mass spectrometer equipped with a Finnigan ESI inter-
face. Data were processed with the Finnigan Xcalibur software system (Thermo-
Quest, Breda, The Netherlands). For off-line MS studies, all peaks of the pre-
parative separation were introduced by continuous infusion using a syringe pump
(Hamilton, NV) at a flow rate of 5 l/min. Spectra were recorded in positive
mode over a period of 2 min and averaged. The scan range was m/z 310 to 1200
at a scan rate of 0.20 s. For the MS/MS experiments, helium was used as the
collision gas. Only a single parent ion was kept in resonance (isolation width m/z
3); all other ions were ejected from the trap without mass analysis. The ion was
then agitated and allowed to fragment by collision-induced dissociation. A col-
lision energy of 22% was used to give 	90% yield of fragmentation. For NMR,
fractions were dissolved in CD3OD (99.9 atom% D; Acros) and transferred to a
standard 5-mm NMR tube. NMR spectra were recorded at a probe temperature
of 25°C on a Bruker DPX-400 (1H, correlation [COSY], total correlation
[TOCSY], nuclear Overhauser effect [NOESY], 13C, distortionless enhancement
by polarization transfer [DEPT], and heteronuclear multiple bond correlation
[HMBC] spectroscopy) or a Bruker AMX 500 (1H, heteronuclear multiple
quantum coherence [HMQC] spectroscopy) spectrometer, both from the
Wageningen NMR Centre. Chemical shifts are expressed in ppm relative to
dimethyl sulfoxide (
 1H 2.50, 
 13C 39.52). One- and two-dimensional double
quantum filtered COSY, TOCSY, NOESY, HMBC, and HMQC spectra were
acquired using standard pulse sequences delivered by Bruker. The mixing time
for the TOCSY was 80 ms, and that for the NOESY was 200 ms.
The analysis of the D/L configurations of the constituting amino acids was
carried out as described by Gerard et al. (15) with some modifications. In short,
2 mg of purified lipopeptide was dissolved in 4 ml of 6 M HCl and heated at
110°C for 24 h in a closed glass vial. The HCl solution was removed in a fume
hood by blowing a stream of N2 over the solution at 45°C. The residue was
dissolved in 250 l of isopropanol saturated with HCl gas and then heated in a
closed vial at 110°C for 45 min. After cooling the solvent was removed with N2
as before. The residue was dissolved in 250 l of CH2Cl2, and 100 l of penta-
fluoropropionyl anhydride was added. After the vial was closed, it was heated at
110°C for 15 min. The reagent solution was removed with N2 as before and
redissolved in 200 l of CH2Cl2, and 1 l was injected (split 1:100) onto a 25-m
Chiralsil-Val Heliflex gas chromatography (GC) column installed in an Agilent
6890 GC equipped with both a mass selective detector and an flame ionization
detector. Other parameters were as follows: injector, cooled injection system
starting at 100°C and going to 240°C at 10°C/s; temperature program, 60°C (hold
for 2 min) to 170°C at 4°C/min. Helium was used a carrier gas. Amino acids were
identified by comparing the retention time and mass spectrum with authentic
reference D- and L-amino acids.
Massetolide A production and transcription of massA, massB, and massC.
Cells were grown in a 24-well plate with 1.25 ml KB broth per well and shaking
at 220 rpm at 25°C. At specific time points, 1 ml of cell culture was collected and
spun down. The cells were frozen in liquid N2 and stored at80°C. For the RNA
isolations and cDNA synthesis, four biological replicates were used for each time
point. Massetolide A production was measured qualitatively by the drop collapse
assay and quantitatively by tensiometric analysis of the cell-free supernatant (K6
tensiometer; Kru¨ss GmbH, Hamburg, Germany) at room temperature. To get
sufficient volume for the tensiometric analysis, the supernatants of four biological
replicates were collected and pooled for each time point. The surface tension of
each sample was measured in triplicate. RNA was isolated from the frozen
bacterial cells with Trizol reagent (Invitrogen), followed by DNase I (GE Health-
care) treatment. One microgram of RNA was used for cDNA synthesis with
Superscript III (Invitrogen) according to the manufacturer’s protocol. For the
Q-PCR, conducted with the 7300SDS system from Applied Biosystems, the
SYBR green core kit (Eurogentec) with a final concentration of 3.5 mM MgCl2
was used according to the manufacturer’s protocol. The concentrations of the
primers were optimized (400 nM final concentration for all), and a dissociation
curve was performed to check the specificity of the primers. The primers used for
the Q-PCR were as follows: for massA, 5-GCTGTACAACATTGGCGGCT-3
(forward) and 5-GGTATGCAGTTGAGTGCGTAGC-3 (reverse); for massB,
5-AACAACGACCGGAGATGCC-3 (forward) and 5-AAGGTGTGCAGCA
AGTGATGG-3 (reverse); for massC, 5-GTCGACCCTCAACGCGTCT-3
(forward) and 5-CCACCGACAGTTGGTCAAGC-3 (reverse); for the 16S
rRNA gene, 5-GCGCAACCCTTGTCCTTAGTT-3 (forward) and 5-TGTGT
AGCCCAGGCCGTAA-3 (reverse); and for rpoD, 5-GCAGCTCTGTGTCC
GTGATG-3 (forward) and 5-TCTACTTCGTTGCCAGGGAATT-3 (re-
verse). To correct for small differences in template concentration, the 16S rRNA
gene and rpoD were used as housekeeping genes. The cycle where the SYBR
green fluorescence crosses a manually set threshold cycle (CT) was used to
determine transcript levels. For each gene the threshold was fixed based on the
exponential segment of the PCR curve. The CT value for massA was corrected
for the housekeeping gene as follows: CT  CT(massA)  CT(rpoD). The same
formula was used for massB and massC. The relative quantification (RQ) values
were calculated by the formula RQ  2[CT(mutant)  CT(wild type)]. If there is no
difference in transcript level between mutant and wild type, than RQ  1 (20)
and log RQ  0. Q-PCR analysis was performed in duplicate (technical repli-
cates) on four independent RNA isolations (biological replicates). Statistically
significant differences were determined for log-transformed RQ values by anal-
ysis of variance (P  0.05) followed by the Bonferroni and Dunnet post hoc
multiple comparisons.
Motility and biofilm. The motilities of wild-type strain SS101 and the masse-
tolide A-deficient mutants were assessed on soft (0.6% agar, wt/vol) standard
succinate medium (SSM) [32.8 mM K2HPO4, 22 mM KH2PO4, 7.6 mM
(NH4)2SO4, 0.8 mM MgSO4, 34 mM succinic acid, adjusted pH to 7 with NaOH].
Overnight cultures of SS101 and the mutants were washed three times, and 5 l
of a cell suspension (1  1010 cells/ml) was spotted in the center of the soft SSM
agar plate and incubated for 48 to 72 h at 25°C. Biofilm formation was assessed
according to the method described by O’Toole et al. (37) using flat-bottom
96-well plates made of transparent polystyrene (Greiner) with 200 l KB broth
per well. Statistically significant differences were determined with Student’s t test
(P  0.05).
Nucleotide sequence accession numbers. The sequences of the contig contain-
ing massA and the contig containing massB and massC have been deposited in
GenBank under accession numbers EU199080 and EU199081, respectively.
RESULTS AND DISCUSSION
Cloning and sequencing of the massA, massB, and massC
genes. Five mutants, designated 10.24, 17.18, 1G12, 9.26, and
11.17, deficient in massetolide A production were obtained by
random mutagenesis. HPLC analysis confirmed that each of
these five mutants did not produce massetolide A or any of the
other massetolide derivatives produced by wild-type strain
SS101 (data not shown) (10). Southern hybridization showed
that each of the five mutants contained a single transposon
integration. Subsequent cloning and sequencing of the regions
flanking the transposon revealed that the transposon had in-
tegrated in NRPS genes. A BAC library was constructed from
the SS101 genome to clone and sequence the complete gene
cluster for massetolide A biosynthesis. The clones in the BAC
library had an average insert size of 55 kb and covered 7.5
genome equivalents. The library was screened by hybridization
with probes corresponding to specific sequences flanking the
transposon insertions, resulting in seven positive BAC clones
(Fig. 1A). Based on restriction analysis, hybridization patterns,
and BAC end sequencing, the seven clones aligned in two
contigs, of which clones 2H12 and 7B4 were completely se-
quenced (Fig. 1A). On the first contig (64 kb), one large ORF
of 6,270 bp, designated massA, was identified and predicted to
encode an NRPS of 2,089 amino acids (aa) with a mass of 230
kDa. On the second contig (80 kb), two large ORFs were
identified: one ORF of 12,924 bp, designated massB, was pre-
dicted to encode an NRPS protein of 4,307 aa with a mass of
469 kDa; the second ORF, of 11,328 bp and designated massC,
was predicted to encode an NRPS protein of 3,775 aa with a
mass of 410 kDa. No overlap was found between the two
contigs, indicating that massA is disconnected from massB and
massC (Fig. 1A). Collectively, massA, massB, and massC span
a region of 30.5 kb (Fig. 1). Site-directed mutagenesis of each
of these three NRPS genes with pKnockout-G (57) generated
mutants that were deficient in massetolide A biosynthesis. In
addition, complementation of the transposon mutants 10.24
(massA), 17.18 (massB), and 9.26 (massC) with pME6031-
massA and pME6031-massBC, respectively, restored massetol-
ide A biosynthesis, which was confirmed by a drop collapse
VOL. 190, 2008 MASSETOLIDE A BIOSYNTHESIS IN P. FLUORESCENS 2779
 at W
ageningen UR Library on April 25, 2008 
jb.asm.org
D
ow
nloaded from
 
assay and HPLC analysis. These results confirm the role of
massA, massB, and massC in massetolide A biosynthesis.
Putative promoter and terminator sequences were identified
for each of the three mass genes (Fig. 1B). For massA, the 35
(TTGATG) and 10 (TTATAAAAT) putative promoter re-
gions were identified at 221 and 213 bp upstream of massA,
respectively. A putative terminator sequence was identified by
RNA secondary structure analysis; sense (TGTAGGAGCGA
GCTTGCTCGCGAAAA) and antisense stem-loops were
identified with a G of 51.6 kcal/mol at 500 and 574 bp down-
stream of massA, respectively. For massB, the35 (TTACCA)
and 10 (CGGCAGACT) putative promoter regions were
identified at 412 and 394 bp upstream of massB, respectively.
Sense (GCCTGGCGC) and antisense stem-loops were iden-
tified with a G of 23 kcal/mol at 520 and 548 bp downstream
of massB, respectively. For massC, the 35 (CTCACT) and
10 (CTATGTGAT) putative promoter regions were identi-
fied at 1,290 and 1,310 bp upstream of massC, respectively, and
are located in the 3 region of massB. Sense (GCCCCACCA
CTCGGCACCTCGCCTAGGCTCGGTGTGCCCG) and an-
tisense stem-loops with a G of 94.9 kcal/mol were identified
at 144 and 567 bp downstream of massC.
Characteristics of massetolide A synthetases. Analysis of
the deduced NRPS amino acid sequences revealed two mod-
ules in MassA, four in MassB, and three in MassC. Each
module consists of C, A, and T domains, and in MassC two TE
domains also were identified (Fig. 1B). The N-terminal C do-
main in MassA clusters closely with C1 domains of other
NRPS involved in CLP biosynthesis (Fig. 2) and is presumably
involved in N acylation of the first amino acid of the CLP
molecule (8, 46). In silico analysis of the substrate specificity of
the nine A domains and subsequent prediction of the amino
acids in the CLP peptide moiety based on signature sequences
(6, 8, 53) were consistent with the chemically determined struc-
ture of the peptide moiety of massetolide A (Fig. 1B). These
results indicate that massA is the first and massC the last gene
involved in massetolide A biosynthesis and that the nine mod-
ules in the massetolide biosynthetic template are colinear with
the number of amino acids in massetolide A.
Chiral GC analysis performed in this study confirmed that
the peptide moiety of massetolide A produced by P. fluorescens
SS101 contains 4 aa in the L configuration (aa 1, 5, 7, and 9)
and 5 amino acids in the D configuration (aa 2, 3, 4, 6, and 8)
(Fig. 1B). In contrast to CLP biosynthetic templates in Bacillus
species (40, 51), no epimerization (E) domains were found in
the massetolide A synthetases (Fig. 1B) or in any of the other
six CLP biosynthetic templates described to date for Pseudo-
monas (4, 8, 17, 18, 39, 45, 48, 59). Roongsawang et al. (45)
initially postulated that external racemases may be responsible
for the D configuration of the amino acids in arthrofactin and
that sequence differences downstream of a conserved core
motif [FFELGGHSLLA(V/M)] in the T domains might reflect
FIG. 1. (A) Representation of the contig assembly of BAC clones 2F11, 3G1, 2H12, 7F11, 6F12, 8G2, and 7B4. The first contig (64 kb) harbors
the massA gene, and the second contig (80 kb) contains the massB and massC genes. (B) Organization of the CLP gene cluster identified in P.
fluorescens SS101 by sequence analysis of BAC clones 2H12 and 7B4. The three genes designated massA, massB, and massC are responsible for
massetolide A biosynthesis. In the genome of strain SS101, massA is disconnected from massB and massC. Underneath the genes are the module
and domain organization of MassA, MassB, and MassC. The domains are as follows: C, condensation; A, adenylation; T, thiolation; and TE,
thioesterification. Underneath the domains are the amino acids that are incorporated into the CLP peptide moiety. The number associated with
the amino acid refers to the position of the amino acid in the CLP peptide chain. Triangles represent the positions of the single transposon
disruptions in the massABC genes obtained by random mutagenesis. The arrows indicate putative promoter sequences, and the closed circles
represent putative terminator sequences. For each of the three mass genes, double arrows indicate the locations of the primers used for Q-PCR.
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FIG. 2. Phylogenetic analysis of amino acid sequences of 51 C domains identified in the known CLP biosynthesis clusters for massetolide A
(mass), arthrofactin (arf), syringomycin (syr), and syringopeptin (syp). C domains predicted to have both condensation and epimerase activities are
referred to as dual C/E domains and are indicated above the dotted line, whereas C domains predicted to function only in condensation (i.e.,
conventional C domains) are found below the dotted line. The C domains of the massetolide A biosynthesis cluster are boxed. Exceptions in this
classification of C domains are indicated with an arrow followed by the upstream donor substrate. Dab, 2.4-diaminobutyric acid. C domains that
are presumably involved in linking the fatty acid to the first amino acid of the CLP peptide moiety are the so-called C1 domains. The numbers
at the nodes indicate the level of bootstrap support higher than 500, based on neighbor-joining analysis of 1,000 resampled data sets. The bar
indicates the relative number of substitutions per site. The abbreviations in the tree indicate the gene and the C domain number, which refers to
the module number in the CLP cluster.
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the recognition by these external racemases. However, when
sequences of the T domains of massetolide A were aligned,
alone or together with T domains of other CLP biosynthesis
clusters, including arthrofactin, no relationship could be estab-
lished between this sequence motif and the amino acid config-
uration (data not shown). Subsequent studies on arthrofactin
biosynthesis by Balibar et al. (2) had indicated that the D
configuration of the amino acids is generated by specific C
domains that have dual catalytic activities, i.e., condensation
and epimerization. In their study, they showed that this sub-
class of C domains, referred to as C/E domains, is involved in
epimerization of the amino acid that is loaded onto the T
domain of the preceding module. Given that aa 2, 3, 4, 6, and
8 have the D configuration in massetolide A (Fig. 1B), this
would suggest that the C domains of the third, fourth, fifth,
seventh, and ninth modules should fall within this subclass of
C/E domains. Subsequent alignment of the primary sequence
of each of the individual C domains from NRPS genes involved
in massetolide A, arthrofactin, syringomycin, and syringopep-
tin biosynthesis showed that C domains 3, 4, 5, 7, and 9 from
massetolide A indeed cluster with the C/E domains of arthro-
factin, syringomycin, and syringopeptin (Fig. 2). There were,
however, two exceptions: based on the alignment, the second
and sixth C domains from massetolide A were also predicted to
have dual catalytic activity but follow an L-Leu residue (aa 1
and A5) (Fig. 2). Also Balibar et al. (2) also found three
exceptions for syringopeptin (i.e., C5, C13, and C22 of syrin-
gopeptin synthetase [Fig. 1B]) and suggested that these C/E
domains could also function as dual condensation/dehydration
domains with or without prior epimerization.
Subsequent analysis of the primary sequence of the pro-
posed C/E domains for massetolide A biosynthesis further
revealed that they harbor the elongated His motif HHI/L
xxxxGD in the N-terminal sequence (Fig. 3A), as was described
for arthrofactin (2). This elongated His motif is present in
addition to the conventional His motif found more down-
stream in all C domains (data not shown). Moreover, the
second His and terminal Asp in this elongated His motif have
been shown to be critical for catalysis in both condensation and
epimerase domains (2, 3, 54). These essential amino acids of
the elongated His motif are present in the predicted C/E do-
mains C3, C4, C5, C7, and C9 of the massetolide A synthetases
(Fig. 3A). The second and sixth domains in the massetolide A
synthetases also have an elongated His motif, but in the C2
domain the Gly in front of the Asp is missing, and in the C6
domain the second His is replaced by a Tyr (Fig. 3A). Whether
these deficiencies affect or eliminate epimerase activity is not
known.
MassC terminates with two TE domains of approximately
250 aa, each containing the conserved GxSxG sequence motif
(Fig. 3B) (45, 47). Both TE domains of MassC contain the
residues Ser80, Asp107, and His207 (Fig. 3B), which form a
catalytic triad in the TE domain of SrfA to -C, the synthetases
involved in surfactin biosynthesis in Bacillus (5). These results
suggest that both TE domains in MassC are likely to be active
in massetolide A biosynthesis and may function in tandem to
enhance the rate of product release from the NRPS assembly
line, as was shown for the two TE domains in arthrofactin
biosynthesis (45, 47).
Organization of the massetolide biosynthesis genes and
identification of flanking regions. Compared with other
Pseudomonas CLP biosynthesis genes described to date (4, 8,
17, 18, 39, 45, 48, 59), the massA, massB, and massC genes
showed highest similarity (81 to 84% identity) to viscA, viscB,
and viscC of P. fluorescens SBW25, respectively (Fig. 4). Up-
stream of massA, two additional ORFs were found (Fig. 4).
The first ORF, of 1,424, bp showed 75% identity with the outer
membrane protein NodT (44) of P. fluorescens Pf0-1, belong-
ing to the family of resistance nodulation and cell division
(RND) efflux systems. The tripartite RND efflux system
PseABC, identified at the left border of the syr-syp genomic
island in Pseudomonas syringae pv. syringae, encodes an outer
membrane protein (PseA), a periplasmic membrane fusion
protein (PseB), and a cytoplasmic membrane protein (PseC)
(21). Mutations in each of the pseABC genes resulted in a
significant decrease (40 to 60%) in syringomycin and syringo-
peptin production (21). Interestingly, the predicted RND-like
outer membrane protein flanking massA showed only 30%
identity to PseA (Psyr_2620) but 69% identity to another outer
membrane protein found in P. syringae pv. syringae. This other
membrane protein, designated Psyr_2606, is also located close
to the syr-syp genomic island (49), but its function in transport
of syringomycin and syringopeptin is, to our knowledge, not yet
known. Given that homologs of the RND-like outer membrane
protein upstream of massA are also found upstream of the
biosynthesis clusters for viscosin, orfamide, and syringomycin/
syringopeptin (Fig. 4), we postulate that this gene plays a role
in transport of massetolide A and other CLPs produced by
Pseudomonas.
The predicted gene product of ORF 2, located upstream of
massA, belongs to the group of LuxR-type transcriptional reg-
ulators which are also found upstream of other Pseudomonas
CLP biosynthesis clusters (Fig. 4). This ORF shows 49% iden-
tity to syrF, which is involved in regulation of syringomycin
biosynthesis (30, 56). The role of this LuxR-type regulator in
massetolide A biosynthesis is yet unknown, but preliminary
results showed that overexpression of this gene resulted in an
increased production of massetolide A in strain SS101 (data
not shown). Downstream of massA, ORFs 3, 4, and 5 were
identified, with 76% identity to mannosyltransferase, 69%
identity to the melittin resistance protein PqaB, and 50% iden-
tity to the Ais protein (aluminum-induced protein), respec-
tively (Fig. 4). These three ORFs are also found downstream
of viscA in P. fluorescens SBW25, but their role in massetolide
A or viscosin biosynthesis, if any, has not been resolved. Lo-
cated even more downstream of massA are two ABC trans-
porters (ORFs 6 and 7) and a hypothetical protein (ORF 8).
Although close homologs of ORFs 6 through 8 were identified
downstream of viscA in P. fluorescens SBW25 and in the ge-
nomes of other CLP-producing Pseudomonas strains, their role
in CLP biosynthesis remains elusive. The ABC transporters
flanking massA have relatively low identity (25%) to SyrD,
an ABC transporter involved in virulence and lipopeptide
transport in Pseudomonas syringae pv. Syringae (42).
Upstream of massB and massC, an 11.3-kb ORF showing
61% identity to an outer membrane transport barrel of P.
fluorescens Pf0-1 was identified. The presence of this gene close
to the CLP biosynthesis cluster seems to be unique for strain
SS101, since it is not found near any of the other CLP biosyn-
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thesis clusters described to date. Downstream of massB and
massC, two ORFs with 84 to 85% identity to the ABC-type
macrolide efflux proteins MacA and MacB of P. fluorescens
Pf-5 were identified. In E. coli, this transport system confers
resistance against the macrolides erythromycin and azithromy-
cin (24). The presence of these genes downstream of the CLP
biosynthesis cluster is conserved among CLP-producing
pseudomonads (Fig. 4), suggesting that the MacA and MacB
homologs may play a role in CLP transport. ORF 4, located
downstream of the macA and macB genes, has 63% identity
with a LuxR-type transcriptional regulator of P. fluorescens
Pf0-1. Homologs of this gene are also found downstream of the
viscosin and orfamide biosynthesis clusters in P. fluorescens
strains SBW25 and Pf-5, respectively, but show relatively low
identity (39%) to salA, an important LuxR-type transcriptional
regulator of syringomycin and syringopeptin biosynthesis (22,
23, 30, 31). Site-directed mutagenesis of the LuxR-type regu-
lators of the massetolide A biosynthesis cluster, as performed
for strain DC3000 (4), as well as expression analyses should be
conducted to more conclusively assess their functions in mas-
setolide A biosynthesis in P. fluorescens. Collectively, these
results indicate that the massetolide A biosynthesis cluster,
including flanking genes, is most closely related to the viscosin
biosynthesis cluster in P. fluorescens SBW25 and harbors spe-
cific features found in other known CLP biosynthesis clusters.
Identification of massetolide A derivatives in P. fluorescens
SS101. Previous results obtained by De Souza et al. (10) indi-
cated that P. fluorescens SS101 produces at least four other
CLPs in addition to massetolide A. In this study, conditions to
separate these putative CLPs were optimized and resulted in
nine peaks corresponding to compounds having molecular
masses ranging from 1,112 to 1,158 Da (Fig. 5). ESI-MS/MS
and NMR analyses confirmed that the main peak, with a re-
tention time of 91.3 min, is massetolide A. The peaks with
retention times of 62.9 and 79.4 min were identified by ESI-
MS/MS and NMR as viscosin and massetolide D, respectively
(Fig. 5). Viscosin differs from massetolide A by the replace-
ment of the allo-isoleucine at aa 4 with a valine, and masse-
tolide D differs from massetolide A by the replacement of the
isoleucine at aa 9 with a leucine (Fig. 5). Based on ESI-MS/MS
studies, the small peaks at 47.2 and 54.7 min were tentatively
identified as massetolides E and F, respectively. Massetolides
E and F resemble viscosin, with the only difference being that
at aa 9 a valine replaces the isoleucine in massetolide E and a
leucine replaces the isoleucine in massetolide F. The molecular
FIG. 3. (A) Alignment of the amino acid sequences of the 51
(C) domains identified in the known CLP biosynthesis clusters encod-
ing the synthetases of massetolide A (mass), arthrofactin (arf), syrin-
gomycin (syr), and syringopeptin (syp). The C domains of the masse-
tolide A biosynthesis cluster are boxed. The conserved motif (HHI/
LxxxxGD) for C domains with dual catalytic activity for condensation
and epimerization is indicated by arrows. The abbreviations in the
alignment indicate the gene and the C domain number, which refers to
the module number in the CLP cluster. (B) Alignment of the amino
acid sequences of 11 TE domains identified in known CLP biosynthesis
clusters encoding the synthetases of massetolide A (mass), viscosin
(visc), orfamide (orf), arthrofactin (arf), syringomycin (syr), and syrin-
gopeptin (syp). The TE domains of the massetolide A biosynthesis
cluster are boxed. The conserved motif (GxSxG) for TE domains is
indicated by arrows. Also indicated are Ser80, Asp107, and His207, which
form a catalytic triad of the TE domain in the NPRS encoding surfac-
tin biosynthesis. The abbreviations in the alignment indicate the gene
and the TE domain number, referring to the first or second TE do-
main.
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weight and MS/MS spectrum of massetolide F are identical to
those of viscosin. The small amounts available precluded the
recording of HMBC NMR spectra for further confirmation.
For the peaks at 51.3 and 57.0 min, the amounts available were
also too small for NMR, and assignment of a putative structure
was not possible on basis of MS data alone. The peak at 65.0
min showed exactly the same MS/MS fragmentation as masse-
tolide A, which suggests that the leucine at either aa 5 or 7 is
replaced by an isoleucine. The peak at 68.7 min has a molec-
ular mass of 1,126. MS/MS and NMR data indicated that it has
a valine as aa 9 instead of an isoleucine in massetolide A. This
compound has, to our knowledge, not been described before
and was given the name massetolide L (Fig. 5). For all eight
fractions, the lipid tail was identified as 3-hydroxydecanoic
acid.
None of the five massetolide A biosynthesis mutants (Fig.
1B) produces any of the derivatives of massetolide A, indicat-
ing that these derivatives are the result of flexibility in amino
acid selection and activation by the A domains of the masse-
tolide A synthetases, and in particular A domains 4 and 9.
Substrate flexibility of A domains is a common phenomenon in
nonribosomal peptide synthesis, resulting in the production of
a range of structural analogs that may have different biological
functions or activities. For example, Gerard et al. (15) showed
that for the massetolides produced by a marine Pseudomonas
strain, variations at the fourth and ninth amino acid positions
FIG. 4. Identification of the flanking genes of massA, massB, and massC based on Blastx analysis. Indicated are the codes of the genes of other
CLP-producing Pseudomonas strains present in the databases PseudoDB and Pseudomonas.com and the percentage of identical amino acids. Gene
homologs shown in gray have an identity higher than 50% but are not located in close vicinity to CLP biosynthesis genes. SBW25, viscosin-
producing P. fluorescens strain; Pf-5, orfamide-producing P. fluorescens strain; B728a, syringomycin- and syringopeptin-producing P. syringae pv.
syringae strain; MIS36, arthrofactin-producing Pseudomonas sp. strain.
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resulted in a significant change in antibacterial activity. Al-
though massetolide A is the most predominant CLP produced
by P. fluorescens SS101, culture conditions may have a signifi-
cant effect on the production of these structural analogs. For
example, carbon sources and the nature of amino acids added
to the culture medium may greatly affect the production levels
and structural diversity of CLPs (11) and may also be exploited
in precursor-directed biosynthesis to generate structurally
novel derivatives with different activities (15).
Relationship between cell density, massetolide A produc-
tion, and transcription of mass genes. Cell density is an im-
portant feature in the regulation of CLP biosynthesis in several
Pseudomonas strains (43). Production of viscosinamide, tensin,
and amphisin occurs in the late exponential growth phase or
stationary phase (34). Also, in Pseudomonas putida PCL1445,
putisolvin production occurs at the end of the exponential
growth phase (28). For P. fluorescens SS101, tensiometric anal-
ysis of cell-free culture supernatant showed a significant drop
in the surface tension already after 12 h of growth, i.e., during
the early exponential growth phase (Fig. 6A). The growth rate
of each of the three mass mutants was similar to that of wild-
type strain SS101, but no reduction in surface tension of the
culture supernatant was observed (Fig. 6A). To investigate the
relationship between massetolide A production and expression
of each of the three mass genes, RNA was isolated from sam-
ples taken at specific time points (8, 12, 16, and 24 h) in the
growth curve and cDNA was subjected to Q-PCR with differ-
ent primers specific for each of the three mass genes (positions
of the primers are indicated in Fig. 1B). Transcript levels were
determined in four independent RNA isolations and related to
transcript levels of the housekeeping gene rpoD to correct for
small differences in template concentration; correction with
16S rRNA gene transcript levels gave similar results (data not
shown). During growth of wild-type strain SS101, transcript
levels of massA, massB, and massC increased over time, reach-
ing a maximum after 16 h of growth (Fig. 6B). Analysis of
transcript levels of the mass genes in each of the three mutants
was performed after 12 and 16 h of growth. The results show
that at both time points, massC transcript levels were signifi-
cantly and consistently decreased in the massB mutant but
FIG. 5. (A) HPLC profile of a crude surfactant extract of P. fluorescens SS101. The main peak (peak 9) represents massetolide A. The identities
of the other eight peaks are given in panel B. (B) Peak numbers, retention times, names, and masses (m/z) of the pseudomolecular ions and amino
acid sequence of the peptide moiety for each of the peaks in the chromatogram shown in panel A.
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were not affected in the massA mutant (Fig. 6C and D).
Transcript levels of massA and massB were variable between
the two time points but were not substantially and consistently
changed in all three mutants, indicating that initiation of tran-
scription was not affected (Fig. 6C and D). These results show
that transcript levels of massA, massB, and massC follow the
same dynamics as the growth and biosurfactant production by
strain SS101. A mutation in massB strongly reduces massC
expression, suggesting that these two genes function in an
operon.
Collectively, these results indicate that under the culture
conditions used in this study, massetolide A biosynthesis is
initiated in the early exponential growth phase. Although the
results obtained with strain SS101 do not point to cell density-
dependent regulation of massetolide A production, various
methods were adopted to investigate whether N-acylhomo-
serine lactone (N-AHL)-mediated quorum sensing plays a
role. When strain SS101 was coinoculated with the N-AHL
reporter strains Chromobacterium violaceum O26 (32), Pseudo-
monas aureofaciens 30-84I (41), Agrobacterium tumefaciens
NTLR4 (32, 52), E. coli pSCR1 (1), and E. coli pSB401 (58), no
response of these N-AHL reporter strains was observed (data
not shown). Furthermore, to separate putative metabolites
produced by SS101 that may inhibit the induction of the N-
AHL reporters, cell-free supernatant from stationary-phase
cultures of SS101 were extracted with ethyl acetate and sepa-
rated by HPLC, followed by overlay thin-layer chromatography
analysis with C. violaceum CV026 as the reporter strain (29,
50). This approach also did not provide any indications of
N-AHL production by strain SS101 (data not shown). Taken
together, these results strongly suggest that, under the condi-
tions tested, N-AHL-dependent quorum sensing does not ap-
pear to play a role in massetolide A biosynthesis in P. fluore-
scens SS101. Similar results were found for viscosin
biosynthesis in P. fluorescens SBW25 (data not shown). in the
biosynthesis of amphisin and syringomycin, N-AHL-mediated
quorum sensing also does not appear to play a role, even
though these CLPs are produced in the late exponential and
stationary growth phases (34). The fact that N-AHL-mediated
quorum sensing does play a role in viscosin biosynthesis in the
plant pathogenic P. fluorescens strain 5064 (7) and in putisolvin
biosynthesis in P. putida strain PCL1445 (12) indicates that this
type of regulation is strain dependent.
Role of massetolide A in swarming and biofilm formation.
The role of CLP production in surface motility and biofilm
formation is well established for other Pseudomonas strains (8,
FIG. 6. (A) Growth of SS101 and the massA, massB, and massC mutants at 25°C in liquid KB medium. Circles, SS101; triangles, massA;
diamonds, massB; squares, massC. Closed symbols correspond to cell density, and open symbols correspond to the surface tension of the
cell-free culture supernatant. Error bars represent standard deviations. OD600, optical density at 600 nm. (B) Transcript levels of massA, massB,
and massC corrected for the transcript levels of the housekeeping gene rpoD [CT CT(mass gene)  CT(rpoD)]. (C and D) Transcript levels of massA,
massB, and massC in SS101 and in the massA, massB, and massC mutants after 12 h (C) and 16 h (D) of growth. For each time point, transcript
levels are presented relative to the transcript level in wild-type SS101 (log RQ), with RQ  2[CT(mutant)  CT(wild type)]. For each time point, mean
values for four biological replicates are given. Error bars represent the standard errors of the means.
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17, 28, 43, 45). Soft agar assays performed in this study showed
that the massA, massB, and massC mutants also were
completely impaired in surface motility, as was shown previ-
ously for viscosin-deficient mutants of P. fluorescens SBW25
(8). Microtiter plate assays showed that the massA, massB,
and massC mutants produced significantly less biofilm than
wild-type strain SS101 (Fig. 7). The biofilm formed by SS101
was located mostly at the air-liquid interface. The deficiency in
biofilm formation of the mutants was restored by complemen-
tation (Fig. 7). The complemented mutants produced even
more biofilm than wild-type strain SS101, which is most likely
due to the copy number (n  5 to 7 [19]) of the vector used to
reintroduce massA and massBC in the mutants. The role of
CLPs in biofilm formation can differ considerably between
different strains. For example, arthrofactin and putisolvin were
shown to adversely affect biofilm formation, since mutants
deficient in the biosynthesis of these CLPs produced more and
differently structured biofilms than their respective parental
strains (28, 45). How CLPs influence biofilm formation is still
unclear, but their effect on cell surface hydrophobicity may
play an important role in this process. Hydrophobic interac-
tions and surface-active compounds, including CLPs, have
been widely suggested to play a role in the adherence of cells
to surfaces (33, 36, 38). More specifically, biosurfactants may
be oriented with the hydrophilic part to the cell surface,
thereby exposing the hydrophobic part to the outside and fa-
cilitating attachment to hydrophobic surfaces; when the orien-
tation is the other way around, i.e., when the hydrophobic part
of the biosurfactant is anchored in the outer layers of the cell
surface, the cell can interact with a hydrophilic surface but not
with a hydrophobic interface (33). Given the diversity in struc-
tures and hydrophobicities of various CLPs produced by
Pseudomonas strains, we postulate that depending on the cell
surface of the producing strain as well as the structure and
hydrophobicity of the CLP produced, the role in biofilm for-
mation may be entirely different.
Conclusion. CLPs are produced by a variety of microorgan-
isms and have activity against a wide range of plant and human
pathogenic microorganisms, including fungi, oomycetes, envel-
oped viruses, mycoplasmas, trypanosomes, and gram-positive
bacteria (43). Insight into the biosynthesis, regulation, and
transport of these versatile compounds can ultimately be ex-
ploited in combinatorial biosynthesis to generate new deriva-
tives with more specific or different activities (14, 43). The
mutagenesis, BAC cloning, sequencing, complementation, and
in silico analysis performed in this study revealed that masse-
tolide A biosynthesis is governed by three large NRPS genes.
Although other CLP biosynthesis genes have been identified
previously for Pseudomonas species, the complete massetolide
A biosynthesis cluster was unknown. Furthermore, in contrast
to other Pseudomonas CLP biosynthesis clusters, the mass
genes are not physically linked in the SS101 genome but are
organized in two separate clusters that are transcribed inde-
pendently. The only Pseudomonas CLP biosynthesis cluster
known to date, for which the genes are also physically discon-
nected, is the viscosin biosynthesis cluster in P. fluorescens
FIG. 7. Role of massetolide A in biofilm formation on an artificial surface by P. fluorescens SS101, its mutants, and the mutants complemented
with massA or massBC. Wells of microtiter plates were filled with 200 l of KB broth and inoculated with strain SS101 or its mutants at an initial
density of 1  108 cells/ml. After incubation for 24 h at 25 °C, cells were stained with crystal violet, wells were washed, and cells attached to the
walls of the microtiter wells were quantified spectrophotometrically (optical density at 600 nm [OD600]). Asterisks indicate statistically significant
(P  0.05) differences relative to wild-type SS101. Error bars represent the standard errors of the means.
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SBW25, where viscA is separated from viscBC by 1.6 Mb on the
physical map of the draft genome sequence (8). Several flank-
ing genes of the massetolide A biosynthesis cluster are con-
served among other Pseudomonas CLP biosynthesis clusters
and include LuxR-type transcriptional regulators, ABC trans-
port carriers, and an RND-like outer membrane protein. Al-
though their function in massetolide A biosynthesis needs to be
assessed, the conserved positioning of these genes suggests an
important role in CLP biosynthesis. Interestingly, no genes
involved in the biosynthesis of the lipid side chain or in acyl
transfer were found up- or downstream of the massetolide
biosynthesis genes. Similar observations were made for the
orfamide biosynthesis cluster (17) and other CLP gene clusters
(43). Gross et al. (17) postulated that the hydroxy fatty acids
composing the lipid side chains of these CLPs may be pro-
duced by the primary metabolism, i.e., the type II fatty acid
synthase systems.
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